Table 1.

Basic characteristic features of studied patients.

Patient ID#	Gender	Age	Cancer type	Stage	Type of therapy
1	F	70	Lung adenocarcinoma	IV	Chemo., Atezolizumab
2	M	50	Lung squamous cell carcinoma	IIIA	Chemo., Atezolizumab
3	M	61	Lung adenocarcinoma	II	Chemo., Atezolizumab
4	F	52	Lung adenocarcinoma	II	Chemo., Atezolizumab
5	M	67	Urothelial carcinoma	IV	Chemo
6	M	64	Renal cell carcinoma	IV	Chemo
7	M	62	CRPC	IV	Chemo
8	M	68	CRPC	IV	Chemo
9	M	73	CRPC	IV	Androgen deprivation
10	M	69	CRPC	IV	Androgen deprivation
11	M	76	CRPC	IV	Chemo
12	M	79	CRPC	IV	Chemo
13	M	55	CRPC	IV	Chemo
14	F	57	Renal cell carcinoma	IV	Chemo
15	M	45	Renal cell carcinoma	IV	None
16	M	85	CRPC	IV	Androgen deprivation